Q3 2026 13F filing
Updated 6 days ago356 disclosed positions worth $8.2B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S STATE STR SPDR S&P 500 ETF T | $1.9B | 2.45M | 22.90% | — |
| 2 | E ISHARES TR | $1.4B | 5.00M | 17.03% | — |
| 3 | S STATE STR SPDR S&P 500 ETF T | $686.4M | 900.0K | 8.41% | — |
| 4 | E ISHARES TR | $444.6M | 1.60M | 5.45% | — |
| 5 | S SUPERNUS PHARMACEUTICALS | $109.7M | 2.55M | 1.34% | — |
| 6 | C CYTOKINETICS INC | $105.5M | 1.60M | 1.29% | — |
| 7 | M AGIOS PHARMACEUTICALS INC | $86.5M | 2.60M | 1.06% | — |
| 8 | M AGIOS PHARMACEUTICALS INC | $85.7M | 2.58M | 1.05% | — |
| 9 | P PTC THERAPEUTICS INC | $84.1M | 1.30M | 1.03% | — |
| 10 | N NEUROCRINE BIOSCIENCES INC | $80.2M | 565.3K | 0.98% | — |
| 11 | C CYTOKINETICS INC | $77.8M | 1.18M | 0.95% | — |
| 12 | T TRAVERE THERAPEUTICS INC | $75.9M | 1.29M | 0.93% | — |
| 13 | R RIGEL PHARMACEUTICALS INC | $74M | 1.54M | 0.91% | — |
| 14 | I INCYTE CORP | $72.8M | 600.0K | 0.89% | — |
| 15 | N NEUROCRINE BIOSCIENCES INC | $70.9M | 500.0K | 0.87% | — |
| 16 | C CYTOKINETICS INC | $63.3M | 960.0K | 0.78% | — |
| 17 | I IRONWOOD PHARMACEUTICALS INC | $59.5M | 15.00M | 0.73% | — |
| 18 | P PTC THERAPEUTICS INC | $58.9M | 910.0K | 0.72% | — |
| 19 | I IMMUNOVANT INC | $58.7M | 1.74M | 0.72% | — |
| 20 | H HARMONY BIOSCIENCES HLDGS IN | $56.4M | 1.44M | 0.69% | — |
| 21 | F FRESHPET INC | $51.2M | 888.7K | 0.63% | — |
| 22 | M MADRIGAL PHARMACEUTICALS INC | $46.4M | 92.0K | 0.57% | — |
| 23 | A AMAZON COM INC | $46.3M | 185.8K | 0.57% | — |
| 24 | V VERASTEM INC | $46.1M | 5.72M | 0.56% | — |
| 25 | M MINERALYS THERAPEUTICS INC | $44.4M | 1.77M | 0.54% | — |
| 26 | P PTC THERAPEUTICS INC | $44.1M | 680.0K | 0.54% | — |
| 27 | D DYNE THERAPEUTICS INC | $43.1M | 2.68M | 0.53% | — |
| 28 | R REGENERON PHARMACEUTICALS | $43M | 56.7K | 0.53% | — |
| 29 | M MADRIGAL PHARMACEUTICALS INC | $42.8M | 85.0K | 0.52% | — |
| 30 | T TRAVERE THERAPEUTICS INC | $42.4M | 720.0K | 0.52% | — |
| 31 | N NEKTAR THERAPEUTICS | $42.4M | 700.0K | 0.52% | — |
| 32 | M MADRIGAL PHARMACEUTICALS INC | $40.3M | 80.0K | 0.49% | — |
| 33 | M MINERALYS THERAPEUTICS INC | $40.2M | 1.60M | 0.49% | — |
| 34 | M MONGODB INC | $37.8M | 108.3K | 0.46% | — |
| 35 | G GSK PLC | $34.9M | 724.0K | 0.43% | — |
| 36 | I IMMUNOCORE HLDGS PLC | $34.4M | 1.14M | 0.42% | — |
| 37 | I INTUITIVE SURGICAL INC | $34.1M | 83.9K | 0.42% | — |
| 38 | O ORTHOFIX MED INC | $34.1M | 3.62M | 0.42% | — |
| 39 | S SANOFI SA | $34M | 824.0K | 0.42% | — |
| 40 | U UBER TECHNOLOGIES INC | $33.3M | 486.6K | 0.41% | — |
| 41 | M MICROSOFT CORP | $33.2M | 64.7K | 0.41% | — |
| 42 | U UNITEDHEALTH GROUP INC | $33M | 90.0K | 0.40% | — |
| 43 | I DISC MEDICINE INC | $32.7M | 500.0K | 0.40% | — |
| 44 | G ALPHABET INC | $32.7M | 95.0K | 0.40% | — |
| 45 | S SOLID BIOSCIENCES INC | $32.5M | 4.50M | 0.40% | — |
| 46 | G GITLAB INC | $31.2M | 660.7K | 0.38% | — |
| 47 | F FIVE9 INC | $29.8M | 876.0K | 0.37% | — |
| 48 | I IMMUNOVANT INC | $29.6M | 875.0K | 0.36% | — |
| 49 | A AXOGEN INC | $29M | 692.0K | 0.36% | — |
| 50 | X DENTSPLY SIRONA INC | $28.7M | 3.24M | 0.35% | — |